Conversations around rescheduling cannabis usually center around how such a move will affect the adult-use cannabis industry. However, the bigger impact of such a move could be on medical marijuana. If the plant is rescheduled from a Schedule I drug to Schedule III, cannabis would be on par with most …
Author: Extroverting
The Daily Hit: October 17, 2024
The Daily Hit is a recap of the top financial news stories for Thursday, October 17, 2024. On the Site Starbuds busted for Starbucks copycat logo Starbuds has to quit using the name and logo and destroy all products containing the images. Read more here. Kentucky approves medical cannabis framework …
Illinois cannabis revenue drops for the first time
This story was republished with permission from Crain’s Chicago. Statewide marijuana sales revenue in Illinois dropped 2% in September, the first year-over-year decline since recreational cannabis became legal in the state four years ago. Sales totaled $136.5 million last month, down from $139.5 million a year ago and $147.4 million in …
Canopy Growth pays down $100M in debt, extends loan maturity
Canopy Growth Corp. (TSX: WEED) (Nasdaq: CGC) prepaid $100 million of its term loan at a discount, the company said Thursday. The Canadian cannabis company said it paid $97.5 million to reduce the loan by $100 million, a move expected to save about $14 million annually in interest expenses. The …